United States · FDA National Drug Code directory
ULORIC
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64764-918_16c36a5a-2f72-4df7-aa6f-1ca27a39404f
- Product NDC
- 64764-918
- Form
- TABLET
- Composition / generic term
- febuxostat
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20090213
- Source listing expiry
- 20261231
Source-listed ingredients
- FEBUXOSTAT — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (64764-918-11) / 10 TABLET in 1 BLISTER PACK · 64764-918-11
- 500 TABLET in 1 BOTTLE (64764-918-18) · 64764-918-18
- 30 TABLET in 1 BOTTLE (64764-918-30) · 64764-918-30
- 90 TABLET in 1 BOTTLE (64764-918-90) · 64764-918-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →